link to RWJMS home page
banner image

Debabrata Banerjee, Ph.D.


Selected Publications:


Xie, X., Bansal, N., Shaik, T., Kerrigan, J.E., Minko, T., Garbuzenko, O., Abali, E.E.,  Johnson-Farley, N., Banerjee, D., Scotto, K. W., Bertino, J. R.   A novel peptide that  inhibits E2F transcription and regresses prostate tumor xenografts. Oncotarget.  2014 Feb 28;5(4):901-7. PubMed PMID: 24658650; PubMed Central PMCID: PMC4011592.

 

Xie, X., Kerrigan, J.E., Minko, T., Garbuzenko, O, Lee, K..C., Scarborough, A, Abali, E.E., Budak-Alpdogan, T., Johnson-Farley N., Banerjee D., Scotto K. W., Bertino, J. R. Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer. Cancer Biol Ther. 2013 Aug 1;14(8):742-51. doi: 10.4161/cbt.25184.  Epub 2013 Jun 3. PubMed PMID: 23792570.

 

Hsieh, Y. C., Tedeschi, P., Adebisi Lawal, R., Banerjee, D., Scotto, K., Kerrigan, J. E., Lee, K.C., Johnson-Farley, N., Bertino, J.R., Abali, E.E.  Enhanced degradationn of dihydrofolatem  reductase through inhibition of NAD kinase by nicotinamide analogs. Mol Pharmacol. 2013 Feb;83(2):339-53. doi: 10.1124/mol.112.080218.  Epub 2012 Nov 29. PubMed PMID: 23197646.

 

Roussel, B., Johnson-Farley, N., Kerrigan, J.E., Scotto, K.W., Banerjee, D., Felczak, K., Pankiewicz, K.W., Gounder, M, Lin, H., Abali, E.E., Bertino, J.R.  A second target of benzamide riboside: dihydrofolate reductase. Cancer Biol Ther. 2012; Nov;13(13):1290-8. doi: 10.4161/cbt.21786. Epub 2012 Sep 6. PubMed PMID: 22954684; PubMed Central PMCID: PMC3493437.

 

Rattigan, Y.I., Patel, B.B., Ackerstaff,  A., Sukenick, G., Koutcher, J.A., Glod, J.W., Banerjee, D. (2012)  Lactate is a mediator of metabolic cooperation between stromal carcinoma ssociated fibroblast cells and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res. 2012. 318(4):326-35. (cited 12 times)

 

Barboza, N., Medina, D, Aracil, M., Jimeno, J.M., Bertino, J.R. and Banerjee, D. (2012)  Plitidepsin (Aplidin) is a Potent Inhibitor of Diffuse Large Cell and Burkitt's Lymphoma and is Synergistic with Rituximab. In Press.  Cancer Biology and Therapy. 2012.

 

Mishra, P.J., Mishra, P.K. and Banerjee, D. (2012).  Cell Free derivatives from mesenchymal Stem Cells are effective in wound therapy.  World J of Stem Cells. 2012. 4(5).35-43.

 

Anton, K., Banerjee, D., Glod, J. (2012). Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion. PLoS One. 2012;7(4):e35036. Epub 2012 Apr 4. PubMed PMID: 22496888; PubMed Central PMCID: PMC3319627.

 

Greco, S.J., Patel, S.A., Bryan, M., Pliner, L.F., Banerjee, D., Rameshwar,  P. (2011). AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells. Am J Cancer Res 2011; 1:701-715.

 

Koneru R., Kobiler, D., Lehrer, S., Li J., van Rooijen, N., Banerjee, D., Glod, J. (2011). Macro,phages play a key role in early blood brain barrier reformation after hypothermic brain injury. Neurosci Lett. 2011; 501(3):148-51.

 

Moroz, M.A., Kochetkov, T., Cai, S., Wu, J., Shamis, M., Nair, J., de Stanchina, E., Serganova, I., Schwartz, G.K., Banerjee, D, Bertino, J.R., Blasberg, R.G. (2011). Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imaging. Clin. Cancer Res. 2011 Mar 1;17(5):1099-110

 

Rattigan, Y, Hsu, J-M., Mishra, P.J., Glod, J,. and Banerjee, D. (2010). IL-6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res. 2010. 316.3417-3424. (cited 14 times)

 

Picinich, S.C., Glod, J.W., Banerjee, D. (2010).  Protein kinase C zeta regulates interleukin-8-mediated stromal-derived factor-1 expression and migration of human mesenchymal stromal cells. Exp Cell Res. 2010. 316.593-602 (cited 8 times)

 

Mishra, P.J., Song, B., Mishra, P.J., Wang, Y., Humeniuk, R., Banerjee, D., Merlino, G., Ju, .J, Bertino, J.R. (2009).  PLoS One.  2009 4(12):e8445.

 

Mishra, P.J., Menon, L.G., Mishra, P.J., Mayer-Kuckuk, .P, Bertino, J.R., Banerjee, D. (2009). Translational modulation of proteins expressed from bicistronic vectors. Mol. Imaging. 2009. 8(6):305-18.

 

Gao, H., Priebe, W., Glod, J., and Banerjee, D.  (2009).  Activation of STAT3 and focal adhesion kinase FAK by SDF-1 is required for migration of human mesenchymal stem cells in response to tumor cell conditioned medium. Stem Cells. 2009. 27(4):857-865 (cited 70 times)

 

Humeniuk, R., Mishra, P.J., Bertino, J.R., and Banerjee, D. (2009)  Epigenetic Reversal of Acquired Resistance  to 5-Fluorouracil Treatment.  Mol. Can. Ther. 2009 8:1045-1054

 

Humeniuk, R, Menon, L.G., Sowers R., Gorlick R., Pizzorno, G., Rode, W., Cheng, Y-C., Kemeny, N.E., Bertino, J.R., and Banerjee, D. (2009) Decreased UMPK levels as mechanism of fluoropyrimidine resistance. Mol Can Ther. 8:1037-1044  

 

Mishra, P., Mishra, P.K.J., Humeniuk, R., Medina, D., Alexe, G., Mesirov, J., Ganesan, S., Glod, J. and Banerjee, D. (2008).  Carcinoma associated fibroblast like differentiation of Bone marrow derived mesenchymal stem cells. Cancer Research.  68(11):4331-9. (Cited 255 times)

 

Lin, S-Y., Yang, J., Everett, A.D., Clevenger, C.V., Koneru, M., Kamen,B., Banerjee, D. and Glod ,J. (2008).  The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.  Experimental Cell Research. 314(17):3107-17.

 

Humeniuk, R., Menon, L.G., Mishra, P.J., Saydam, G., Longo-Sorbello, G.S., Elisseyeff, Y., Lewis, L.D., Aracil, M., Jimeno, J., Bertino, J.R., and  Banerjee D.  Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.  Leukemia. 2007 Dec;21(12):2399-405.

 

Mishra, P.J., Humeniuk, R., Mishra, P.J., Longo-Sorbello, G.S., Banerjee, D., Bertino, J.R.  A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.  Proc Natl Acad Sci U S A. 2007 Aug 14;104 (33):13513-13518. (Cited 247 times)

 

Menon, L.G., Picinich, S.C., Koneru, R., Gao, H., Lin, S-Y., Koneru, M., Mayer-Kuckuk, P., Glod, J.W., and Banerjee, D.  Differential Gene Expression Associated with Migration of Mesenchymal Stem Cells to Conditioned Medium From Tumor Cells or Bone Marrow Cells.  Stem Cells. 2007.25.520-528. (Cited 90 times)

 

Russo, A., Magro, P.G., Hu, Z., Li, W.W., Peters, R., Mandola, M., Banerjee, D. and Bertino, J.R.  E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2kinase activity and sensitizes cells to antimitotic agents. Cancer Res. 66(14):7253-60.

 

Mayer-Kuckuk, P., Doubrovin, M., Bidaut, L., Budak-Alpdogan, T., Cai, S., Hubbard, V., Alpdogan, O., van den Brink, M., Bertino, J.R., Blasberg, R.G., Banerjee, D., and Gelovani, J. (2006) Molecular Imaging Reveals  Skeletal Engraftment Sites of Transplanted Bone Marrow Cells.  Cell Transplantation. 15 (1).75-82.

 

Mayer-Kuckuk, P., Gade, T.P., Doubrovin, M., Boskey, A., Blasberg, R.G., Koutcher, J.A., Bertino, J.R. and  Banerjee, D. (2005)  High Resolution Imaging of Bone Precursor Cells within the Intact Bone Marrow cavity of Living Mice.  Mol Ther. 12(1):33-41.

 

Skacel, N.E., Menon, L.G., Mishra, P.J., Peters, R., Banerjee, D., Bertino, J.R. and Abali, E.E. (2005)  Identification of amino acids required for the functional up-regulation of human dihydrofolate   reductase protein in response to antifolate Treatment.  J Biol Chem. 280(24):22721-31

 

Capiaux, G.M., Budak-Alpdogan, T., Alpdogan, O., Bornmann, W., Takebe, N., Banerjee, D., Maley, F., Bertino, J.R. (2004) Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene. Cancer Gene Ther. Dec;11(12):767-73.

 

Budak-Alpdogan, T., Alpdogan, O., Banerjee, D., Wang, E., Moore, M.A.S., and Bertino, J.R. (2004). Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.  Mol Ther. 10, 574-584

 

Magro, P.G., Russo, A.J., Li, W.W., Banerjee, D.,. and Bertino, J.R. (2004)  p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with non functional p53. Cancer Res. 64,4338-4345

 

Iwamoto, M., Banerjee, D., Menon, L.G., Jurkiewicz, A., Rao, P.H., Kemeny, N., Fong, Y., Jhanwar, S.C., Gorlick, R. and Bertino, J.R. (2004)  Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification.  Cancer Biology and Therapy. 3 (4). 395-9 (joint first authors)

 

Mayer-Kuckuk, P., Doubrovin, M., Gusani, N., Gade, T., Balatoni, J., Akhurst, T., Finn, R., Fong,Y., Koutcher, J.A., Larson, S., Blasberg, R., Gelovani-Tjuvayev, Y., Bertino, J.R and Banerjee, D. (2003)  Imaging dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats. Eur.J.Nuc.Med and Molec.Imaging. 30,1281-1291.

 

Sowers, R., Toguchida, J., Qin J., Meyers, P.A., Healey, J.H., Huvos, A., Banerjee, D., Bertino J.R., and Gorlick R. (2003)  mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma. Mol. Cancer Ther. 2: 535-41

 

Capiaux, G.M., Budak-Alpdogan, T., Takebe, N., Mayer-Kucku,k P, Banerjee, D, Maley, F, and Bertino JR. (2003) Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-Fluorouracil. Hum Gene Ther. 14(5):435-46.

 

Gonen M, Hummer A, Zervoudakis A, Sullivan D, Fong Y, Banerjee, D, Klimstra D, Cordon-Cardo C, Bertino J, and Kemeny N. (2003)  Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.  J. Clin. Oncol. 21(3):406-12. (Cited 34 times)

 

Mayer-Kuckuk, P., Banerjee, D., Malhotra, S., Doubrovin, M., Iwamoto, M., Akhurst, T., Balatoni, J., Bornmann, W., Finn, R., Larson, S., Fong, Y., Tjuvayev, J.G., Blasberg, R.G. and Bertino ,J.R. (2002)  Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase:A method to modulate gene expression.  Proc. Natl. Acad. Sci. U.S.A. 99.3400-3405. (Cited 32 times)

 

Banerjee, D. and Liefshitz, A. (2001).  Potential of the proteasomal inhibitor MG-312 as an anticancer agent, alone and in combination.  Anticancer Research. 21 (6). 3941-3948.

 

Adhikari D., Feroz F., Liefshitz A., Barakat R., Bertino, J.R., and Banerjee, D. (2000) Pretreatment of endometrial carcinoma cell lines with butyrate results in upregulation of Bax and correlates with potentiation of radiation induced cell kill.  In Vivo. 14(5). 260-268.

 

Banerjee D., Gorlick, R., Liefshitz, A., Danenberg, K.D., Fong, Y., Kemeny, N. and Bertino, J.R. (2000).  Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Research.60,2365-2367. (Cited 46 times)

 

Sauerbrey, A., McPherson, J.P., Zhao, S.C., Banerjee, D., and Bertino, J.R. (1999). Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside.  Hum.Gene. Ther.10,2495-2504.

 

Hochhauser, D., Valkov, N.I., Gump, J.L., Wei, I., O’Hare, C., Hartley, J., Fan, J., Bertino, J.R., Banerjee, D., and Sullivan, D.M. (1999).  Effects of wild-type p53 expression on the quantitity and activity of topoisomerase IIa and b in various human cancer cell lines.  J. Cell.Biochem. 75.245-257.

 

Li, W.W., Fan, J., Banerjee, D., and Bertino, J.R. (1999).  Overexpression of p21 decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.  Mol Phramacol. 55.1088-1093.

 

Banerjee, D., Schnieders, B., Adhikari, D., Fu, J. and Bertino, J.R. (1998).  Role of E2F-1 in chemosensitivity.  Cancer Res. 58, 4292-4296. (Cited 58 times)

 

Tong, Y., Liu-Chen, X., Ercikan-Abali, EA., Zhao, SC. Banerjee, D., Maley F. and Bertino, J.R. (1998)  Probing the folate binding site of human thymidylate synthase by site directed mutagenesis.  J .Biol.Chem. 273,31209-31214. (Cited 22 times)

 

Tong, Y., Liu-Chen, X., Ercikan-Abali, E.A., Capiaux, G.M., Zhao, S.C. Banerjee, D., and Bertino, J.R. (1998).  Isolation and characterization of Thymitaq and FudR resistant mutants of human thymidylate synthase from EMS exposed human sarcoma HT1080 cells.  J.Biol.Chem. 273,11611-11618. (Cited 29 times)

 

Flasshove, M., Banerjee, D., Leonard, J.P., Mineishi, S. Li, M.-X.,Bertino, J.R. and Moore, M.A.S. (1998)  Retroviral transduction of human CD34+ Umbilical cord blood progenitor cells with a mutated human dihydrofolate reductase cDNA.  Human Gene Therapy. 9,63-71.

 

Lenz, H.J., Hayashi, K., Salonga, D., Danenberg, K.D., Danenberg, P.V., Metzger, R., Banerjee, D.,, Bertino, J.R., Groshen, S., Leichman, L.P., Leichman, C.G. (1998) p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival. Clin Can.Res. 4.1243-1250. (Cited 122 times)

 

Gorlick, R., Metzger, R., Danenberg, K.D., Salonga, D., Miles, J.S., Longo, G.S.A., Fu, J., Banerjee, D., Klimstra, D., Jhanwar, S., Danenberg, P.V., Kemeny, N. and Bertino, J.R. (1998) Higher levels of Thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J.Clin.Oncol. 16. 1465-1469. (Cited 62 times)

 

Ju, J., Banerjee, D., Lenz, H-J., Danenberg, K.D., Schmittgen, T., Schonthal, A., Manno, D.J., Hochhauser, D., Bertino, J.R. and Danenberg, P.V. (1998)  Restoration of wild type p53 activity in p53 null HL-60 cells confers multidrug sensitivity. Clin.Cancer Res. 4.1315-1322.

 

Flasshove, M., Banerjee, D., Leonard, J., Li, M-X., Bertino, J.R. and Moore, M.A.S. (1998). Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA. Hum.Gene.Therapy 9,69-73.

 

Ercikan-Abali, E.A., Banerjee, D., Waltham, M.C., Skacel, N., Scotto ,K.W. and Bertino, J.R. (1997). Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region. Biochemistry. 36,12317-12322.

 

Banerjee, D., Zhao, S.C., Mineishi, S. and Bertino J.R.(1997). Post transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA. Hum.Gene.Therapy. 8. 903-907.

 

Fan, J., Banerjee, D., Stambrook, P.J. and Bertino, J.R. (1997). Modulation of cytotoxicity of chemotherapeutic drugs by activated H-ras. Biochem. Pharmacol. 53.1203-1209.

 

Mineishi, S., Nakahara, S., Takebe, N., Banerjee, D., Zhao, S.C. and Bertino, J.R. (1997). Co-expression of the Herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene. Gene.Therapy. 4.570-576.

 

Ercikan-Abali, E., Mineishi, S., Tong, Y., Nakahara, S., Waltham, M.C., Banerjee, D., Sadelain, M. and Bertino, J.R. (1996). Active site-directed double mutants of dihydrofolate reductase. Cancer Res. 56,4142-4145.

 

Hochhauser, D., Schnieders, B., Ercikan-Abali, E., Gorlick, R., Muise-Helmericks, R., Li W.W., Fan, J., Banerjee, D., and Bertino, J.R.(1996). Effect of Cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. J.N.C.I.88,1269-1275.

 

Ercikan-Abali, E., Waltham, M., Dicker, A.P., Gritsman, H., Banerjee, D., and Bertino, J.R. (1996)Amino acid residue 22 mutations of human dihydrofolate reductase. Effect on catalytic and inhibitor binding properties. Molecular Pharmacology. 47.310-317.

 

Banerjee, D., Lenz, H-J., Schnieders, B., Manno, D.J., Hochhauser, D., Danenberg, K.., Ju, J.F., Danenberg, P.V., and. Bertino, J.R. (1995). Transfection of wild type but not mutant p53 induces early monocytic differentiation in HL60 cells and sensitizes them to stress. Cell Growth and Differentiation.6,1405-1413.

 

Flasshove, M., Banerjee, D., Mineishi,S., Li, M-X., Bertino, J.R. and Moore M.A.S. (1995).  Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood. 85(2). 566-574.

 

Li, W.W., Fan, J., Hochhauser, D., Banerjee, D., Zelinski, Z., Wahl, G.M., Yin, Y., Kelly, R., Almasan, A. and Bertino, J.R. (1995).  Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc.Natl.Acad.Sci. U.S.A. 92.10436-10440.

 

Goker, E., Kheradpour, A., Waltham, M., Banerjee, D., Tong, W.P., Elisseyeff, Y. and Bertino, J.R.  (1995).  Acute Monocytic Leukemia: An ALL subset that may be sensitive to methotrexate.  Leukemia. 9.274-276.

 

Lenz, H-J., Danenberg, K.D., Schnieders, B., Banerjee, D., Bertino, J.R, Leichman, L. and Danenberg, P.V. (1995). Identification of mutations by RNA conformational polymorphism bar code analysis.  Genomics. 30.120-122.

 

Banerjee, D., Zhao, S.C., Tong, Y., Steinherz, J., Gritsman, K. and Bertino, JR. (1994). Transfection of a nonactive site murine mutant DHFR (the Trp15 mutant) into Chinese Hamster Ovary and mouse marrow progenitor cells  imparts Methotrexate resistance in vitro.  Cancer Gene Ther.1(3) 181-184.

 

Banerjee, D., Schweitzer, B.L., Li, M.X., Mineishi, S. and Bertino, J.R. (1994). Transfection of a novel Ser31 or Ser34 mutant human dihydrofolate reductase encoding cDNA into chinese hamster ovary cells and mouse marrow progenitor cells in vitro confers methotrexate resistance  Gene. 139.269-274.

 

Li, M.X., Banerjee, D., Zhao, S.C., Schweitzer, B.I., Mineishi, S., Gilboa, E. and Bertino, J.R. (1994).  Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood. 83(11)3403-3408.  

 

Zhao, S.C., Li, M.X., Banerjee, D., Schweitzer, B.I., Mineishi, S., Gilboa, E. and Bertino, J.R. (1994).  Long term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double copy vector retrovirus containing a mutant dihydrofolate reductase.  Cancer Gene Therapy. 1(1) 27-33.

 

Koch, O.M., Volkenandt, M., Goker, E., Buer, J., Probst, M., Banerjee, D., Danenberg, P.V. and Bertino, J.R. (1994).  Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy chain genes.  Leukemia 8(6)946-952.

 

Banerjee, D., Schnieders, B., Dutta, S.K. and Bertino, J.R. (1993). Detection of a novel double mutation in a ß-thalassemia patient by RNA SSCP and direct sequencing. Blood.82(12)3786-3787.(Letter)

 

Ercikan, E., Banerjee, D., Waltham, M., Schnieders, B., Scotto, K.W. and Bertino, J.R. (1993). Translational regulation of the synthesis of dihydrofolate reductase.  Chemistry and Biology of Pteridines and Folates. in Advances in Experimental Medicine and Biology. 338,537-540.

 

Fanin, R., Banerjee, D., Volkenandt, M.V., Waltham, M. Schweitzer, B.I. and Bertino, J.R. (1993).  Mutations leading to antifolate resistance following exposure of CHO cells to an alkylating agent.  Mol. Pharmacol. 44.13-21.

 

Volkenandt, M.V., Dicker, A.P., Fanin, R., Banerjee, D., Albino, A and Bertino, J.R. (1993).  PCR analysis of DNA from paraffin embedded tissue in "PCR-Selected protocols and applications" B. White ed.  Humana Press. Ch. 8 .81-88.

 

Li, M., Hantzopoulous, P., Banerjee, D., Zhao, S.C., Schweitzer, B.I., Gilboa, E. and Bertino, J.R. (1992). Comparison of the expression of a mutant dihydrofolate reductase under the control of different internal promoters in retroviral vectors. Human Gene Therapy. 3:381-390.

 

Bertino, J.R., Li, W.W., Lin, J.T., Trippett, T., Goker, E.,Schweitzer, B.I. and Banerjee, D. (1992). Enzymes of the Thymidylate cycle as targets for chemotherapeutic agents: Mechanisms of resistance.  Mt.Sinai Journal Of Medicine. 59(5)391-395.

 

Volkenandt, M.V., Dicker, A.P., Banerjee, D., Fanin, R., Schweitzer, B.I., Horikoshi, T., Danenberg, K., Danenberg, P. and Bertino, J.R. (1992)  Quantitation of gene copy number and expression by the Polymerase Chain Reaction. Proc. Soc. Exp.Biol. & Med. 200, 1-6.

 

Volkenandt, M.V., Koch, O., Fanin, R., Banerjee, D., Seger, A., Vogel, A., Bierhoff, E., Heidl, G., Neyses, L. and Bertino, J.R. (1992). Sequence analysis of polymerase chain reaction amplified t(14;18)chromosomal breakpoints in formalin fixed paraffin-embedded follicular lymphoma. J.Clin.Pathol. 45,210-212.

 

Dicker, A.P., Volkenandt, M., Schweitzer, B.I., Banerjee, D. and Bertino, J.R. (1990).  Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate resistant CHO line MTXRIII J. Biol. Chem.265(14). 8317-8321.

 

Mukherjee, G., Banerjee, D., Bhattacharya, D.K. and Chatterjee,G.C. (1990). Effect of Retinoic Acid on ADP and Collagen induced alteration in enzyme activities of GSH linked antioxidant defense system of human blood platelets in vitro. Ind.J.Exp.Biol. 28.550-552.

 

Mukherjee, G., Banerjee, D., Chatterjee, G.C. and Bhattacharya, D.K .(1990). Differential effect of Retinoic Acid on ADP and Collagen induced platelet aggregation. Ind. J. Exp. Biol. 28.949-952.

 

De, M., Banerjee, D., Chandra, S. and Bhattacharya, D.K. (1989).  Detection of hemophilia traits in carriers. Ind. J. Med. Res. 90:85-87.

 

Vanier, M., Banerjee, D. and Mukherjee, B.B. (1988).  Retinoic Acid inhibits phospholipid turnover and PK-C activity in RA sensitive cells but not in RA resistant cells FEBS Letts.241(1,2).154-158.

 

Laverdure, G.R., Banerjee, D., Chackalaparampil, I., and Mukherjee, B.B. (1987). Epidermal and transforming growth factors modulate secretion of a 69 kDa phosphoprotein in normal rat kidney cells.  FEBS Letts. 222(2) 261-266.

 

Banerjee, D., Pentney, R.J.W., Chackalaparampil, I. and Mukherjee, B.B. (1986). Ability of oncogenically transformed cells to grow without anchorage correlates with phosphorylation of a group of low molecular weight plasma membrane proteins.  Exp. Cell. Res. 166.442-454.

 

Chackalaparampil,I., Banerjee, D., Poirier, Y. and Mukherjee, B.B. (1985). Altered processing of a major secreted phosphoprotein correlates with tumorigenicity in RSV transformed mammalian cells.  J.Virol.53.841-850.

 

Banerjee, D., Basu, M., and Chatterjee,,G.C. (1983).  Physical and chemical studies on LPS of A.tumefaciens. Ind.J.Biochem.Biophys.21.16-20.

 

Banerjee, D., Tiwari, R.K., Basu, M., and Chatterjee, G.C.  (1983) Evidence for the involvement of exposed surface carbohydrates of A.tumefaciens in the formation of crown gall tumors. J.Biosciences.5.53-59.

 

Banerjee, D., Basu, M. and Chatterjee, G.C.( 1983). Evidence for the presence of an antigenically distinct protein on the outer membrane of A.tumefaciens. Folia. Microbiol. 28.21-28.

 

Banerjee, D., Basu, M. and Chatterjee, G.C.( 1982). Binding of Actinomycin-D and divalent cations to LPS of A.tumefaciens as studied by fluorescence spectroscopy. Experientia.38. 1064-1067.

 

Basu, M., Banerjee, D. and Chatterjee, G.C.( 1982).Lytic effects of EDTA and lysozyme on virulent and avirulent strains of A.tumefaciens.  Ind.J.Biochem.Biophys. 19.59-61.

 

Basu, M.,Banerjee, D.,Tiwari, R.K., Das, P.K.,. and Chatterjee, G.C.(1982). Biochemical Studies on cytoplasmic membranes of A.tumefaciens. Acta.Microbiol.31.37-45.

 

Banerjee, D., Basu, M. and Chatterjee, G.C. (1982).  Studies on the SOD activities of A.tumefaciens.  Acta.Microbiol. 32.48-54.

 

Banerjee, D., Basu, M., Choudhury, I., and Chatterjee, G.C. (1981). Cell surface carbohydrates of A.tumefaciens involved in adherence during crown gall tumor induction.  BBRC.100.1384-1387.

 

Citations 5531; since 2008: 2840  h-index 41 (since 2008: 22)  i10-index 100  (since 2008: 56)

 

 

Books, Monographs and Chapters

 

Banerjee, D., Tong, Y., Chen, X-L., Capiaux, G. M., Ercikan-Abali, E. A., Takebe, N., O’Connor, O.A., and Bertino, J.R. 1999.  Protection of bone marrow cells from toxicity of chemotherappeutic agents targeted toward Thymidylate synthase by transfer of mutant forms of human Thymidylate synthase cDNA. In Marrow Protection (Transduction of hematopoietic cells with drug resistance genes). Prog. Exp. Tum. Res. Bertino, J.R. ed. Basel. Karger. 36,82-94.

 

Bertino, J. R., Zhao, S. C., Mineishi, S., Ercikan-Abali, E. A. and Banerjee, D.  1999 Use of variants of dihydrofolate reductase in gene transfer to produce resistance to methotrexate and trimetrexate. In Marrow Protection (Transduction of hematopoietic cells with drug resistance genes).  Prog. Exp. Tum. Res. Bertino,J.R. ed. Basel.Karger.36,82-94.

 

Banerjee, D. and Bertino, J. R.  2002.  E2F and Cancer Chemotherapy. In Targets for Cancer Chemotherapy.: Transcription Factors and other Nuclear proteins. Ed N.La Thangue and Lan R. Bandara. Humana Press.Inc. Totowa. N.J. p289-298

 

Mayer-Kuckuk, P., and Banerjee, D.  2008. Molecular Imaging. Ch 3. Cancer Imaging. Ed M.A. Hayat. Elsevier.  .

 

Mishra, P.J., and Banerjee D. "Role of Mesenchymal Stem Cells in Tumor Progression" 1st edition book entitled, "The Tumor Microenvironment" part of the Cancer Drug Discovery and Development series. ed R.Bagley; senior editor B. Teicher. Springer. 2010 ch 13. p185-205.

 

Mishra, P.J. and Banerjee, D. “Activation and differentiation of mesenchymal stem cells”. Signal Transduction Immunohistochemistry: Methods and Protocols.  Methods in Mol Biol. Vol 717. Humana Press. 2011.  Ed A. Kalyuzhny. ch14. p245-253.